BRIDGE Program: Mechanism of Action (MoA) Studies
External Collaboration Program
- Program Objective
- To facilitate technology transfer and advancement to the next development stage by establishing the mechanism of action (MoA) of early-stage drug candidates through practical mechanism studies and securing lead compounds.
- Program Details
- Program period: Apr-Dec, 2026
- Scope of Support: (Small molecule & Antibody)
- Structural and interaction analysis of drug–target protein complexes
- Mechanism analysis reports and strategic consulting
- Expression and purification of target proteins
- Contact
R&D Enabling & Strategy Team: rnd_project@kddf.org